Notes on streptozotocin in metastatic insulinoma.
D007516:Adenoma, Islet Cell / Q000188:drug therapy*; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001344:Autopsy; D001786:Blood Glucose; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D001921:Brain / Q000473:pathology; D005944:Glucosamine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007118:Immunoassay; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007328:Insulin / Q000032:analysis; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D009362:Neoplasm Metastasis; D009536:Niacinamide / Q000627:therapeutic use; D009603:Nitroso Compounds / Q000627:therapeutic use*; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use; D010179:Pancreas / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D013961:Thyroid Gland / Q000473:pathology; D013964:Thyroid Neoplasms / Q000188:drug therapy; D014508:Urea / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D001786:Blood Glucose; D007328:Insulin; D009603:Nitroso Compounds; D009607:Nitrosourea Compounds; D009536:Niacinamide; D014508:Urea; D005944:Glucosamine